These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12455410)

  • 1. HIV-1 integration as a target for antiretroviral therapy: a review.
    Pluymers W; De Clercq E; Debyser Z
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):133-49. PubMed ID: 12455410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of authentic inhibitors of HIV-1 integration.
    Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
    Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of HIV-1 integration.
    Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
    Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
    Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
    Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex.
    Ding J; Zhao J; Yang Z; Ma L; Mi Z; Wu Y; Guo J; Zhou J; Li X; Guo Y; Peng Z; Wei T; Yu H; Zhang L; Ge M; Cen S
    Viruses; 2017 May; 9(5):. PubMed ID: 28489061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations.
    Fikkert V; Van Maele B; Vercammen J; Hantson A; Van Remoortel B; Michiels M; Gurnari C; Pannecouque C; De Maeyer M; Engelborghs Y; De Clercq E; Debyser Z; Witvrouw M
    J Virol; 2003 Nov; 77(21):11459-70. PubMed ID: 14557631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical screening assays to identify HIV-1 integrase inhibitors.
    Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
    Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
    Lin SS; Xu F; Liao PH; Yang CC
    Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M; Debyser Z
    Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor.
    Park KH; Kim M; Bae SE; Lee HJ; Kim KC; Choi BS; Kim YB
    Virol J; 2021 Jan; 18(1):17. PubMed ID: 33436020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
    Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1.
    Beale KK; Robinson WE
    Antiviral Res; 2000 Jun; 46(3):223-32. PubMed ID: 10867160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
    Nair V
    Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
    de Soultrait VR; Desjobert C; Tarrago-Litvak L
    Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.